I am a translational neurobiologist and clinical neurologist with interest in advanced methodological developments that I subsequently apply in my research to address pertinent neurobiological and clinical issues. My scientific interests include blood-brain barrier transport, neurobiology of cerebral blood flow and metabolism and the neuropharmacology with particular emphasis on molecular brain imaging. I am PI of the precision medicine alliance BrainDrugs, funded by the Lundbeck Foundation. The alliance has the aim to identify which features can form a basis for decisions regarding the right treatment for the right patient with either major depressive disorder or epilepsy. I use PET brain scanning to image brain receptors and receptor occupancy, and fMRI to evaluate drug effects on the brain hemodynamic response as well as the brains regional interactions, i.e., functional connectivity.